NCT07496853 Effect of Upper Extremity Support on Spatiotemporal Parameters of Gait in Individuals With Stroke
| NCT ID | NCT07496853 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ankara Yildirim Beyazıt University |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 34 participants |
| Start Date | 2026-04-01 |
| Primary Completion | 2026-12-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 34 participants in total. It began in 2026-04-01 with a primary completion date of 2026-12-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Purpose: The primary goal of this study is to investigate how different levels of upper extremity (arm) support affect walking patterns in individuals who have experienced a stroke. Specifically, the research aims to determine how restricting or facilitating arm swing during walking modulates spatiotemporal gait parameters (such as speed, step length, and rhythm). Background: Arm swing plays a crucial role in maintaining balance, stability, and energy efficiency during normal walking. Following a stroke, many patients use walking aids (like canes or walkers) or clinical supports (like parallel bars) that restrict natural arm movement. This study examines whether these restrictions significantly alter gait mechanics in the stroke population. Methodology: Participants will participate in a cross-over experimental trial. Each participant will walk on a specialized treadmill system (C-Mill VR+) under three randomized conditions: 1. Unsupported walking (no arm support), 2. Single-arm support (using the non-paretic side), 3. Dual-arm support (using both arms). Researchers will record gait speed, step length, cadence, and duration of stance/swing phases for each condition. Expected Outcome: The findings will provide scientific evidence on how different support strategies modulate walking performance. This information will help physical therapists design more effective, individualized rehabilitation programs to improve mobility and quality of life for stroke survivors.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of hemiplegia with ICD-10 code G.81. * Presence of unilateral hemiplegia. * No medical contraindications for the use of assistive devices (e.g., cane, tripod). * Aged 18 years or older. * Ability to walk for at least 2 consecutive minutes. Exclusion Criteria: * Presence of aphasia. * Recurrent stroke. * Montreal Cognitive Assessment (MoCA) score below 10 points.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07496853 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07496853 currently recruiting?
Yes, NCT07496853 is actively recruiting participants. Contact the research team at muratakinci.fzt@gmail.com for enrollment information.
Where is the NCT07496853 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07496853 clinical trial?
NCT07496853 is sponsored by Ankara Yildirim Beyazıt University. The trial plans to enroll 34 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.